 ASLAN Pharmaceuticals NASDAQ: ASLN has closed a secured loan facility provided by K2 HealthVentures K2HV. Under the terms of the facility, K2HV will provide ASLAN up to 45 million of secured debt financing consisting of a 20 million initial term loan funded at closing, with the remaining 25 million subject to specific terms and conditions. 